Clinical Trial Update: Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dexmedetomidine to placebo for sedation during ERCP in pancreatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Pancreatitis | Phase 4 | Status: COMPLETED